Abstract
Loss of heterozygosity (LOH) in the MEN1 region on chromosome 11q13 and MEN1 gene mutations have been found in a subset of sporadic parathyroid tumors. The question of whether these genetic abnormalities in the parathyroid tumors might influence the clinical and biochemical characteristics of primary hyperparathyroidism (PHPT) remains to be elucidated. The aim of the present study was to correlate the presence of MEN1 gene alterations in PHPT tumors with the clinical phenotype. Using microsatellite analysis for LOH at 11q13 and DNA sequencing of the coding exons, the MEN1 gene was studied in 38 parathyroid tumors of patients with sporadic PHPT. Fourteen tumors showed LOH at 11q13, and mutations of MEN1 gene were detected in 7 cases. The clinical and biochemical characteristics of patients were unrelated to the presence or absence of LOH and/or MEN1 gene mutations. In conclusion, MEN1 gene alterations are rather common in sporadic PHPT and their presence does not correlate with the clinical manifestations of the disease.
Similar content being viewed by others
References
Heath H. 3rd, Hodgson S.F., Kennedy M.A. Primary hyperparathyroidism: incidence, morbidity, and potential economic impact in a community. N. Engl. J. Med. 1980, 302: 189–193.
Teh B.T., Esapa C., Houlston R., Grandell U., Farnebo F., Nordenskjod M. Familial isolated hyperparathyroidism associated with a constitutional MEN1 mutations. Am. J. Hum. Genet. 1998, 18: 1544–1549.
Teh B.T., Farnebo F., Twigg S., et al. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21–q32 in a subset of families. J. Clin. Endocrinol. Metab. 1998, 83: 2114–2120.
Bergwitz C., Bremer B., Soudah B., Mayr B., Brabant G., Familial isolated parathyroid adenoma in a consanguineous family. J. Endocrinol. Invest. 2001, 5: 349–355.
Bilezikian J.P., Silverberg S., Gartenberg F., et al. Clinical presentation of primary hyperparathyroidism. In: Bilezikian J.P., Marcus R., Levine M.A. (Eds.), The parathyroids: Basic and clinical concepts. Raven Press, New York, 1994, p. 457.
Arnold A. Molecular mechanisms of parathyroid neoplasia. Endocrinol. Metab. Clin. North Am. 1994, 23: 93–107.
Farnebo F., Kytola S., Teh B.T., et al. Alternative genetic pathways in parathyroid tumorigenesis. J. Clin. Endocrinol. Metab. 1999, 84: 3775–3780.
Tahara H., Smith A., Gaz R., Cryns V., Arnold A. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas. Cancer Res. 1996, 56: 599–605.
Stratakis C.A. Clinical genetics of multiple endocrine neoplasias, Carney complex and related syndromes. J. Endocrinol. Invest. 2001, 5: 370–383.
Chandrasekharappa S., Guru S., Manickam P., et al. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 1997, 276: 404–407.
European Consortium on MEN1 Identification of the multiple endocrine neoplasia type 1. Hum. Mol. Genet. 1997, 6: 1177–1183.
Cetani F., Pardi E., Cianferotti L., et al. A new mutation of the MEN1 gene in an Italian kindred with multiple endocrine neoplasia type 1. Eur. J. Endocrinol. 1999, 140: 429–433.
Bystrom C., Larsson C., Blomberg C., et al. Localization of the gene for multiple endocrine neoplasia type 1 to a small region within chromosome 11q13 by deletion mapping in tumors. Proc. Natl. Acad. Sci. USA 1992, 87: 1968–1972.
Toliat M.R., Berger W., Ropers H.H., Neuhaus P., Wieddenmann B. Mutations in the MEN1 gene in sporadic neuroendocrine tumors of gastroenteropatic system. Lancet 1997, 2: 1223.
Zhuang Z., Ezzat S.Z., Vortmeyer A.O., et al. Mutations of the MEN1 tumor suppressor gene in pituitary tumors. Cancer Res. 1997, 57: 5446–5451.
Heppner C., Kester M.B., Agarwal S.K., et al. Somatic mutation of the MEN1 gene in parathyroid tumors. Nature Genetics 1997, 16: 375–378.
Carling T., Correa P., Hessman O., Hedberg J., Skogseid B., Lindberg D. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 1998, 83: 2960–2963.
Farnebo F., Teh B.T., Kytola S., Svensson A., Phelan C., Sandelin K. Alterations of the MEN1 gene in sporadic parathyroid tumors. J. Clin. Endocrinol. Metab. 1998, 83: 2627–2630.
Potts J.T. NIH Consensus Development Conference Statement on Primary Hyperparathyroidism. J. Bone. Miner. Res. 1991, 6: S9–S13.
Sambrook J., Fitsch E.F., Maniatis T. Molecular Cloning: A laboratory manual, 2nd ed., Vol. 1 and 2. Cold Spring Harbor Laboratory, Cold Spring Harbor, 1989, 1.21–1.24.
Debelenko L.V., Emmert-Buck M.R., Manickam P., et al. Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene. Cancer Res. 1997, 57: 1039–1042.
Cetani F., Pardi E., Giovannetti A., et al. Six novel MEN1 gene mutations in sporadic parathyroid tumors. Hum. Mutat. 2000, 16: 445–448.
Cryns V.L., Yi S.M., Tabara H., Gaz R.D., Arnold A. Frequent loss of chromosome 1p DNA in parathyroid adenomas. Genes Chromosom. Cancer 1995, 13: 9–13.
Marcocci C., Golia F., Bruno-Bossio G., Vignali E., Pinchera A. Carefully monitored levothyroxine therapy is not associated with bone loss in premenopausal women. J. Clin. Endocrinol. Metab. 1994, 78: 818–823.
Arnold A., Kim H.G., Eddy R.L., et al. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J. Clin. Invest. 1989, 83: 2034–2040.
Cetani F., Pinchera A., Pardi E., et al. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. J. Bone. Miner. Res. 1999, 14: 878–882.
Carling T., Imanishi Y., Gaz R.D., Arnold A. RAD51 as a candidate parathyroid tumor suppressor gene on chromosome 15q: absence of somatic mutations. Clin. Endocrinol. 1999, 51: 403–407.
Cryns V.L., Thor A., Xu H.J., Hu S.X., Wierman M.E., Arnold A. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N. Engl. J. Med. 1994, 330: 757–761.
Friedman E., De Marco L., Gejman P.V., et al. Allelic loss from chromosome 11 in parathyroid tumors. Cancer Res. 1992, 15: 6804–6809.
Bhuiyan M.M.R., Sato M., Murao K., Imachi H., Namihira H., Takahara J. Expression of menin in parathyroid tumors. J. Clin: Endocrinol. Metab. 2000, 85: 2615–2619.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cetani, F., Pardi, E., Vignali, E. et al. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism. J Endocrinol Invest 25, 508–512 (2002). https://doi.org/10.1007/BF03345492
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345492